Showing results (151-160 of 292) with videos related to

Sort By:
Pageof 30
Plos One|March 29, 2017
Time spent by Belgian hospital pharmacists on supply disruptions and drug shortages: An exploratory studyElfi De Weerdt, Thomas De Rijdt, Steven Simoens, et al.
Orphanet Journal of Rare Diseases|December 9, 2022
Exploring alternative financing models and early access schemes for orphan drugs: a Belgian case studyKhadidja Abdallah, Kathleen Claes, Isabelle Huys, et al.
Pharmacy World & Science : PWS|November 18, 2006
Use and costs of anti-secretory and cardiovascular co-medication in osteoarthritis patients treated with selective or non-selective NSAIDSSteven Simoens, Sandra De Coster, Bernard De Ruyck, et al.
International Journal of Environmental Research and Public Health|June 26, 2025
Evaluating the Cost-Effectiveness of Air Pollution Mitigation Strategies: A Systematic ReviewBo Vandenbulcke, Nick Verhaeghe, Lisa Cruycke, et al.
Frontiers in Pharmacology|April 25, 2024
Implementing the EU HTA regulation: Insights from semi-structured interviews on patient expectations, Belgian and European institutional perspectives, and industry outlooksThomas Desmet, Maud Brijs, Frank Vanderdonck, et al.
Pharmacoeconomics|September 13, 2011
Critical assessment of belgian reimbursement dossiers of orphan drugsAlain Denis, Lut Mergaert, Christel Fostier, et al.
Expert Opinion on Biological Therapy|March 1, 2025
Drawing on collective action theory to foster sustainable biosimilar markets - insights from co-creation workshops with UK and Belgian stakeholdersTeresa Barcina Lacosta, Arnold G Vulto, Florian Turk, et al.
Frontiers in Pharmacology|June 17, 2017
Adoption of Biosimilar Infliximab for Rheumatoid Arthritis, Ankylosing Spondylitis, and Inflammatory Bowel Diseases in the EU5: A Budget Impact Analysis Using a Delphi PanelTim A Kanters, Jelena Stevanovic, Isabelle Huys, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|February 26, 2024
Can Endangered Biosimilar Markets be Rescued? The Need to Bridge Competing Interests for Long-Term GainTeresa Barcina Lacosta, Arnold G Vulto, Florian Turk, et al.
Pharmaceuticals (Basel, Switzerland)|February 9, 2021
Informing Patients about Biosimilar Medicines: The Role of European Patient AssociationsYannick Vandenplas, Steven Simoens, Philippe Van Wilder, et al.
Pageof 30